Efficacy and Safety of Canakinumab for the Treatment of Anemia in LR-MDS Patients
Clinical trial NCT05237713 · TERMINATED
Trial details
- NCT number
- NCT05237713
- Sponsor
- University of Leipzig
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-26
- Primary completion
- 2024-02-29
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.